technetium tc 99m sestamibi has been researched along with Osteosarcoma in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 8 (57.14) | 29.6817 |
2010's | 4 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, K; Igarashi, K; Kimura, H; Miwa, S; Nishida, H; Ooi, A; Shirai, T; Takeuchi, A; Taki, J; Tanzawa, Y; Tsuchiya, H; Yamamoto, N | 1 |
Gabata, T; Hashimoto, N; Kinuya, S; Saito, J; Taki, J; Tsuchiya, H; Wakabayashi, H | 1 |
Hayashi, K; Miwa, S; Nishida, H; Ooi, A; Shirai, T; Sumiya, H; Takeuchi, A; Taki, J; Tsuchiya, H | 1 |
Huang, ZK; Lou, C; Shi, GH | 1 |
Basdemir, G; Burak, Z; Ersoy, O; Kantar, M; Moretti, JL; Sanli, U; Tamgac, F | 1 |
Charoenvareekul, S; Khunkitti, N; Punyaratabandhu, T; Rajchadara, S; Songpatanasilp, T; Thanakit, V; Wittayawongsaruji, S | 1 |
Abrunhosa, AJ; Botelho, MF; Cleton-Jansen, AM; Gomes, CM; Henriquez, NV; Hogendoorn, PC; Pauwels, EK; Que, I; Romeo, S; van der Pluijm, G; Welling, M | 1 |
Hao, RR; Li, CL; Yang, JG; Zou, LF | 1 |
Bauer, HC; Brosjö, O; Jacobsson, H; Larsson, O; Larsson, SA; Söderlund, V | 1 |
Ahdoot, R; Diggles, L; Kalinowski, EA; Marcus, CS; Minami, C; Moody, T; Pallela, V; Pham, HL; Saeed, S; Thakur, ML | 1 |
Başdemir, G; Burak, Z; Dirlik, A; Erinç, R; Ozcan, Z; Ozkiliç, H; Sabah, D | 1 |
Basdemir, G; Burak, Z; Dirlik, A; Erinç, R; Ersoy, O; Moretti, JL; Ozcan, Z; Sabah, D | 1 |
Antonescu, C; Calleja, E; Daras, M; Gorlick, R; Healey, JH; Huvos, AG; Larson, SM; Liao, AC; Meyers, PA; Panicek, D; Sowers, R; Wexler, LH; Yeh, SD | 1 |
Aras, T; Bekdik, C; Caner, B; Erbengi, G; Kitapçi, M; Uğur, O | 1 |
2 trial(s) available for technetium tc 99m sestamibi and Osteosarcoma
Article | Year |
---|---|
99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Bone Neoplasms; Child; Female; Femoral Neoplasms; Humans; Humerus; Male; Metabolic Clearance Rate; Middle Aged; Multidrug Resistance-Associated Proteins; Osteosarcoma; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic; Technetium Tc 99m Sestamibi; Treatment Outcome | 2003 |
Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Osteosarcoma; Radionuclide Imaging; Radiopharmaceuticals; Regional Blood Flow; Sarcoma; Soft Tissue Neoplasms; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 2001 |
12 other study(ies) available for technetium tc 99m sestamibi and Osteosarcoma
Article | Year |
---|---|
Prognostic value of radiological response to chemotherapy in patients with osteosarcoma.
Topics: Adult; Disease-Free Survival; Female; Humans; Male; Osteosarcoma; Prognosis; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Treatment Outcome | 2013 |
Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma: comparison with (99m)Tc-MIBI scintigraphy.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Osteosarcoma; Preoperative Care; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi; Treatment Outcome; Young Adult | 2016 |
Use of 99mTc-MIBI scintigraphy in the evaluation of the response to chemotherapy for osteosarcoma: comparison with 201Tl scintigraphy and angiography.
Topics: Adolescent; Adult; Aged; Angiography; Antineoplastic Agents; Bone Neoplasms; Child; Female; Humans; Male; Middle Aged; Osteosarcoma; Radionuclide Angiography; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Treatment Outcome | 2011 |
[²⁰¹TI and (99m)Tc-MIBI scintigraphy in evaluation of neoadjuvant chemotherapy for osteosarcoma].
Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Humans; Male; Neoadjuvant Therapy; Osteosarcoma; Preoperative Care; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Young Adult | 2012 |
The correlation of Tc-99m MIBI scintigraphy and histological response in determining the percentage of tumor necrosis in osteosarcoma after preoperative chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Female; Humans; Male; Middle Aged; Necrosis; Osteosarcoma; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2005 |
Functional imaging of multidrug resistance in an orthotopic model of osteosarcoma using 99mTc-sestamibi.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Osteosarcoma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2007 |
Primary osteogenic sarcoma of breast detected on Tc-99m MIBI scintigraphy and Tc-99m MDP skeletal scintigraphy.
Topics: Breast Neoplasms; Female; Humans; Middle Aged; Osteosarcoma; Radionuclide Imaging; Radiopharmaceuticals; Rare Diseases; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 2008 |
Use of 99mTc-MIBI scintigraphy in the evaluation of the response of osteosarcoma to chemotherapy.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Extremities; Female; Humans; Male; Middle Aged; Osteosarcoma; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1997 |
Imaging tumors in humans with Tc-99m-VIP.
Topics: Adenocarcinoma; Adult; Amino Acid Sequence; Autoradiography; Bone Neoplasms; Breast Neoplasms; Female; Humans; Male; Middle Aged; Molecular Sequence Data; Neoplasms; Organotechnetium Compounds; Osteosarcoma; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Vasoactive Intestinal Peptide; Technetium Tc 99m Sestamibi; Vasoactive Intestinal Peptide | 2000 |
The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Child; Drug Resistance, Multiple; Female; Histiocytoma, Benign Fibrous; Humans; Immunohistochemistry; Male; Middle Aged; Muscle Neoplasms; Neoadjuvant Therapy; Osteosarcoma; Phenotype; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma; Technetium Tc 99m Sestamibi | 2001 |
Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma.
Topics: Adolescent; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone and Bones; Bone Neoplasms; Child; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Necrosis; Osteosarcoma; Pilot Projects; Radionuclide Imaging; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Technetium Tc 99m Sestamibi | 2001 |
Increased accumulation of hexakis (2-methoxyisobutylisonitrile)technetium(I) in osteosarcoma and its metastatic lymph nodes.
Topics: Adolescent; Bone Neoplasms; Contrast Media; Humans; Inguinal Canal; Lymphatic Metastasis; Male; Nitriles; Organotechnetium Compounds; Osteosarcoma; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Tibia | 1991 |